aTyr Pharma, Inc. engages in the discovery and development of medicines based on novel biological pathways. Its product pipeline includes ATYR1923, ATYR2810, NRP2 mAbs, and AARS-1, DARS-1. The company was founded by Paul Schimmel, Xiang-Lei Yang and Bruce Beutler on September 8, 2005 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
58
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Atyr Pharma Inc market cap is $9.05M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Atyr Pharma Inc 52 week high is $44.40 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Atyr Pharma Inc 52 week low is $3.69 as of November 21, 2026.
Atyr Pharma Inc stock price today is $3.82.
Atyr Pharma Inc stock price yesterday was $3.69.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Atyr Pharma Inc's P/E ratio is -0.17.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Atyr Pharma Inc P/B ratio is 0.2727.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Atyr Pharma Inc 50-day moving average is $9.19.